„First Line“

Suchergebnisse

3.416 Treffer

• The First Lines of English Grammar
  Brown, Goold 2022 Salzwasser Verlag
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
  Gairing, Simon J. ; Röhlen, Natascha ; Bettinger, Dominik ; Foerster, Friedrich 2025 Universität
• PD-L1-Inhibitor zur First-Line-Therapie von fortgeschrittenem Magenkrebs
  Schumacher, Beate
• Proof Nets for First-Order Additive Linear Logic
  Heijltjes, Willem B. ; Hughes, Dominic J. D. ; Straßburger, Lutz 2019 Schloss Dagstuhl – Leibniz-Zentrum für Informatik
• First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study
  Naganuma, Makoto ; Shiga, Hisashi ; Shimoda, Masayuki ; Matsuura, Minoru ; Takenaka, Kento ; Fujii, Toshimitsu ; Yamamoto, Shojiro ; Matsubayashi, Mao ; Kobayashi, Taku ; Aoyama, Nobuo ; Saito, Daisuke ; Yokoyama, Kaoru ; Moriya, Kei ; Tsuchiya, Kiichiro ; Shibui, Shunsuke ; Kawamoto, Ami ; Shimizu, Hiromichi ; Okamoto, Ryuichi ; Sakamoto, Kazuki ; Yaguchi, Katsuki ; Kunisaki, Reiko ; Akiyama, Shintaro ; Hayashi, Ryohei ; Hasui, Keisuke ; Kanmura, Shuji ; Bamba, Shigeki ; Mishima, Yoshiyuki ; Kakimoto, Kazu
• Analysis of the effectiveness and safety of lenvatinib/bevacizumab combined with PD-1/PD-L1 inhibitors and GEMOX in the first-line treatment of advanced biliary tract carcinoma
  Zhao, Lu ; Zhang, Zhengfeng ; Wang, Dazhen ; Yang, Liu ; Liu, Ze ; Lou, Changjie
• Empfohlene First-Line-Therapien bei Komorbiditäten
• A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China
  Yu, Xuedi ; Kang, Suyi ; Ge, Junjie ; Wang, Jingfu
• Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC study
  Roets, E. ; Younger, E. ; Jones, R. L. ; Hollander, D.den ; Desar, I. M. E. ; Young, R. J. ; Oosten, A. W. ; Haan, J. J. de ; Gelderblom, H. ; Steeghs, N. ; Graaf, W. T. A. van der ; Husson, O.
• Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India
  Singh, Ajaykumar ; Noronha, Vanita ; Patil, Vijay ; Menon, Nandini ; Kapoor, Akhil ; Trikha, Mehak ; Manmode, Sima ; Kaushal, Rajiv ; Pai, Trupti ; Purandare, Nilendu ; Janu, Amit ; Majumdar, Anuradha ; Ubharay, Ahmad Ashfaq Ahmad ; Prabhash, Kumar
• First-line noninvasive management of cytomegalovirus primary infection in pregnancy
  Denef, Marie ; Noel, Laure ; Bruck, Gaëlle ; Gudelj, Justine ; Tebache, Malek ; Viellevoye, Renaud ; Nisolle, Michelle ; Chantraine, Frédéric
• First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: a multicenter study from the prospective skin cancer registry ADOREG
  Reinhard, Sören ; Meiß, Frank ; Stege, Henner Maximilian 2025 Universität
• PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial
  Wang, Yakun ; Lu, Jialin ; Chong, Xiaoyi ; Wang, Chang ; Chen, Xiaofeng ; Peng, Zhi ; Gu, Yanhong ; Wang, Yizhuo ; Wang, Xicheng ; Li, Jian ; Gong, Jifang ; Qi, Changsong ; Yuan, Jiajia ; Lu, Zhihao ; Lu, Ming ; Zhou, Jun ; Cao, Yanshuo ; Chen, Yang ; Zhang, Cheng ; Hou, Zhiguo ; Kou, Hongyi ; Shen, Lin ; Zhang, Xiaotian
• A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma with esophagogastric varices after progression on first-line lenvatinib combined with PD-1 inhibitor
  Li, Saifeng ; Wen, Qin ; Huang, Wenwu ; Qiu, Zeyu ; Feng, Long ; Yi, Fengming
• Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study
  Kato, Daisuke ; Suzuki, Takanori ; Matsuura, Kentaro ; Okayama, Kohei ; Okumura, Fumihiro ; Nagura, Yoshihito ; Sobue, Satoshi ; Hayashi, Katsumi ; Kusakabe, Atsunori ; Hasegawa, Izumi ; Matoya, Sho ; Mizoshita, Tsutomu ; Kimura, Yoshihide ; Kondo, Hiromu ; Ozasa, Atsushi ; Kawamura, Hayato ; Fujiwara, Kei ; Nojiri, Shunsuke ; Kataoka, Hiromi
• Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer
  Cao, Bi-Yang ; Cao, Qi ; Ma, Xiao-Ting ; Ou, Kai ; Yang, Wen-Wei ; Zhang, Le-Tian ; Lu, Jing-Yu ; Jiang, Zhi-Chao ; Zhang, Wen ; Zhang, Jie ; Wang, Qi ; Gao, Li-Zhen ; Yang, Lin
• Comparison analysis of ICIs and chemotherapy combined with or without lenvatinib as first-line treatment of unresectable intrahepatic cholangiocarcinoma
  Li, Miao ; Li, Tong ; Chen, Rongxin ; Wang, Yan
• Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
  Grenda, Anna ; Iwan, Ewelina ; Kuźnar-Kamińska, Barbara ; Bomba, Arkadiusz ; Bielińska, Katarzyna ; Krawczyk, Paweł ; Chmielewska, Izabela ; Frąk, Małgorzata ; Szczyrek, Michał ; Rolska-Kopińska, Anna ; Jankowski, Tomasz ; Kieszko, Robert ; Milanowski, Janusz
• Non-Blocking Dynamic Unbounded Graphs with Worst-Case Amortized Bounds
  Chatterjee, Bapi ; Peri, Sathya ; Sa, Muktikanta ; Manogna, Komma 2022 Schloss Dagstuhl – Leibniz-Zentrum für Informatik
• Brief Announcement: Non-Blocking Dynamic Unbounded Graphs with Worst-Case Amortized Bounds
  Chatterjee, Bapi ; Peri, Sathya ; Sa, Muktikanta 2021 Schloss Dagstuhl – Leibniz-Zentrum für Informatik